A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment.

Trial Profile

A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment.

Completed
Phase of Trial: Phase III

Latest Information Update: 10 May 2017

At a glance

  • Drugs Losartan (Primary)
  • Indications Heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms HEAAL
  • Sponsors Merck & Co
  • Most Recent Events

    • 27 Mar 2012 Results assessing the effects of treatment on renal function presented at the 61st Annual Scientific Session of the American College of Cardiology.
    • 17 Nov 2009 Results published online in the Lancet.
    • 17 Nov 2009 Results presented at the 82nd Annual Scientific Sessions of the American Heart Association (AHA 2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top